Victus granted 510(k) clearance for lens fragmentation procedure
Valeant announced Bausch + Lomb has received 510(k) clearance from the U.S. Food and Drug Administration for the Victus Femtosecond Laser Platform for femtosecond laser-assisted lens fragmentation during cataract and refractive surgery.
The Victus platform provides a variety of lens fragmentation patterns depending on the cataract grade and user preference, according to a company press release.
In February, the FDA cleared the Victus platform for corneal incisions. It is one of the only femtosecond lasers in the U.S. with clearance for the creation of corneal flaps in LASIK surgery, anterior capsulotomy during cataract surgery, penetrating arcuate cuts or incisions in the cornea and laser-assisted lens fragmentation during cataract surgery, according to the release.